Tolvaptan, hyponatremia, and heart failure
- PMID: 21694950
- PMCID: PMC3108793
- DOI: 10.2147/IJNRD.S7032
Tolvaptan, hyponatremia, and heart failure
Abstract
Tolvaptan is the first FDA-approved oral V(2) receptor antagonist for the treatment of euvolemic and hypervolemic hyponatremia, in patients with conditions associated with free water excess such as heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone secretion. Tolvaptan inhibits the binding of arginine vasopressin to the V(2) receptors on the collecting ducts of the kidneys resulting in aquaresis, the electrolytes sparing excretion of water. This article reviews the accumulated experience with tolvaptan and all the major clinical trials that were conducted to study its safety and efficacy and concludes by summarizing clinicians' views of its current application in clinical practice.
Keywords: arginine vasopressin antagonist; heart failure; hyponatremia; tolvaptan.
Similar articles
-
Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.Clin Ther. 2010 Jun;32(6):1015-32. doi: 10.1016/j.clinthera.2010.06.015. Clin Ther. 2010. PMID: 20637957 Review.
-
Tolvaptan: a vasopressin antagonist for the management of euvolemic and hypervolemic hyponatremia.Expert Rev Clin Pharmacol. 2010 Sep;3(5):601-12. doi: 10.1586/ecp.10.45. Expert Rev Clin Pharmacol. 2010. PMID: 22111741
-
Tolvaptan and its potential in the treatment of hyponatremia.Ther Clin Risk Manag. 2008 Dec;4(6):1149-55. doi: 10.2147/tcrm.s3115. Ther Clin Risk Manag. 2008. PMID: 19337422 Free PMC article.
-
Hyponatremia in cirrhosis and end-stage liver disease: treatment with the vasopressin V₂-receptor antagonist tolvaptan.Dig Dis Sci. 2012 Nov;57(11):2774-85. doi: 10.1007/s10620-012-2276-3. Epub 2012 Jun 26. Dig Dis Sci. 2012. PMID: 22732834 Free PMC article. Review.
-
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.N Engl J Med. 2006 Nov 16;355(20):2099-112. doi: 10.1056/NEJMoa065181. Epub 2006 Nov 14. N Engl J Med. 2006. PMID: 17105757 Clinical Trial.
Cited by
-
Efficacy of vaptans for correction of postoperative hyponatremia: A comparison between single intravenous bolus conivaptan vs oral tolvaptan.J Anaesthesiol Clin Pharmacol. 2018 Apr-Jun;34(2):193-197. doi: 10.4103/joacp.JOACP_263_17. J Anaesthesiol Clin Pharmacol. 2018. PMID: 30104827 Free PMC article.
-
Severe Symptomatic Hyponatremia Secondary to Escitalopram-Induced SIADH: A Case Report with Literature Review.Case Rep Nephrol. 2018 Sep 5;2018:3697120. doi: 10.1155/2018/3697120. eCollection 2018. Case Rep Nephrol. 2018. PMID: 30254775 Free PMC article.
-
Efficacy of oral tolvaptan versus 3% hypertonic saline for correction of hyponatraemia in post-operative patients.Indian J Anaesth. 2017 Dec;61(12):996-1001. doi: 10.4103/ija.IJA_581_17. Indian J Anaesth. 2017. PMID: 29307906 Free PMC article.
-
Autosomal dominant polycystic kidney disease and pioglitazone for its therapy: a comprehensive review with an emphasis on the molecular pathogenesis and pharmacological aspects.Mol Med. 2020 Dec 11;26(1):128. doi: 10.1186/s10020-020-00246-3. Mol Med. 2020. PMID: 33308138 Free PMC article. Review.
-
Potential Effectiveness of Tolvaptan to Improve Ascites Unresponsive to Standard Diuretics and Overall Survival in Patients with Decompensated Liver Cirrhosis.Clin Drug Investig. 2016 Oct;36(10):829-35. doi: 10.1007/s40261-016-0434-7. Clin Drug Investig. 2016. PMID: 27405984
References
-
- Ghali JK. Mechanisms, risks, and new treatment options for hyponatremia. Cardiology. 2008;111:147–157. - PubMed
-
- Renneboog B, Vendemergel X, Manto MN, et al. Mild chronic hyponatremia is associated with falls, unsteadiness and attention deficits. Am J Med. 2006;119:71e1–71e8. - PubMed
-
- Sandhu HS, Gilles E, DeVita MV, et al. Hyponatremia associated with large bone fracture in elderly patients. Int Urol Nephrol. 2009;41:733–737. - PubMed
-
- Gankam Kengne F, Andres C, Sattar L, et al. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM. 2008;101:583–588. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
